An interventional study of Virtual Reality-Based Multidomain Intervention and Multidomain Health Education in Frailty and Cognitive Dysfunction, sponsored by Zheng Li. Not yet recruiting. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Zheng Li · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to evaluate the effects of a virtual reality intervention on cognitive and physical function in older adults with cognitive decline or physical frailty.
Cognitive and physical function are essential for maintaining independent living in older adults. This study aims to evaluate the effects of a virtual reality intervention on cognitive and physical function in older adults. Eligible older adults with cognitive decline, physical frailty, or both will be enrolled in a virtual reality intervention group or a control group. The intervention group will receive the virtual reality intervention specified in the study protocol, while the control group will receive the designated control intervention. Participants' cognitive function, physical function, and related health indicators will be assessed before the intervention and at the assessment time points specified in the study protocol. Changes over time will be compared between the two groups to evaluate the effects of the virtual reality intervention on cognitive and physical function. Intervention participation, completion, and withdrawal will be recorded, and intervention process measures will be collected to evaluate the feasibility and safety of the virtual reality intervention in older adults. This study will provide evidence to inform the use of virtual reality interventions to maintain and improve cognitive and physical function in older adults.
1,287 studies on the registry are indexed under Frailty; 454 are open to participants now.
This study's planned enrollment of 246 is above the median of 82 across 769 interventional studies indexed under Frailty.
Browse Frailty studies →Zheng Li is the lead sponsor of 5 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Virtual reality intervention integrating cognitive training, physical exercise, nutrition education, and emotional support.
Behavioral: Virtual Reality-Based Multidomain Intervention
Multidomain health education
Behavioral: Multidomain Health Education
Participants will receive a virtual reality intervention integrating cognitive training, physical exercise, nutrition education, and emotional support. Sessions will be delivered twice weekly for 24 weeks, for a total of 48 sessions. Each session will last approximately 40 minutes including instructions, warm-up activities, structured training, and breaks as needed. Participants will receive guidance to familiarize themselves with the virtual reality equipment before commencing structured training.
Participants will receive multidomain health education covering cognitive health, physical activity, nutrition guidance, and emotional well-being.
Subjective Cognitive Decline
Subjective cognitive decline will be assessed using the nine-item Subjective Cognitive Decline Questionnaire (SCD-Q9). Total scores range from 0 to 9, with higher scores indicating greater subjective cognitive decline. Changes from baseline will be evaluated at each follow-up assessment.
Time frame: Baseline, Week 8, Week 16, and Week 24
Objective Cognitive Function
Objective cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). Total scores range from 0 to 30, with higher scores indicating better cognitive function. Changes from baseline will be evaluated at each follow-up assessment.
Time frame: Baseline, Week 8, Week 16, and Week 24
Frailty
Frailty will be assessed using the Fried Frailty Phenotype (FFP), which includes five components including unintentional weight loss, slow walking speed, low grip strength, low physical activity, and exhaustion. Total scores range from 0 to 5, with higher scores indicating greater physical frailty.
Time frame: Baseline, Week 8, Week 16, and Week 24
Depressive Symptoms
Depressive symptoms will be assessed using the nine-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.
Time frame: Baseline, Week 8, Week 16, and Week 24
Anxiety Symptoms
Anxiety symptoms will be assessed using the Generalized Anxiety Disorder-7 (GAD-7) scale. Total scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.
Time frame: Baseline, Week 8, Week 16, and Week 24
Apathy
Apathy will be assessed using the three-item apathy subscale of the Geriatric Depression Scale (GDS-3A). Total scores range from 0 to 3, with higher scores indicating greater apathy.
Time frame: Baseline, Week 8, Week 16, and Week 24
Economic-related Evaluation
Health-related quality of life will be assessed with the five-level EuroQol five-dimensional questionnaire (EQ-5D-5L). The health utility index will be calculated using the Chinese value set.
Time frame: Baseline and Week 24 (end of the intervention)
Satisfaction and Acceptability of Virtual Reality Technology
Satisfaction and acceptability of virtual reality technology will be assessed using the questionnaire on older adults' acceptance of immersive virtual reality experiences, covering perceived usefulness, perceived ease of use, perceived enjoyment, user experience, and intention to use.
Time frame: At the end of the intervention (Week 24)
Engagement
Engagement will be assessed using the participant intervention process record questionnaire, and higher frequency and longer duration of participation indicate better engagement.
Time frame: Throughout the intervention period, 24 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Oct 2027, 11 months later.
Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 11 months is below that.
Counting every sponsor, half of 518 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zheng Li